TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Claimsfiler
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK

Cytokinetics faces a securities class action lawsuit alleging failure to disclose material information about its FDA drug application process for aficamten, with stock price declining after key disclosures in March and May 2025.

Insights
VYLD   neutral

Maintains a steady portfolio position at 4.0% of assets


CYTK   negative

Company is facing a class action lawsuit for allegedly withholding material information about its drug application process, which led to a stock price drop and potential legal consequences